GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shinpoong Pharmaceutical Co Ltd (XKRX:019170) » Definitions » Total Equity

Shinpoong Pharmaceutical Co (XKRX:019170) Total Equity : ₩268,591 Mil (As of Mar. 2024)


View and export this data going back to 1990. Start your Free Trial

What is Shinpoong Pharmaceutical Co Total Equity?

Shinpoong Pharmaceutical Co's total equity for the quarter that ended in Mar. 2024 was ₩268,591 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Shinpoong Pharmaceutical Co Total Equity Historical Data

The historical data trend for Shinpoong Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shinpoong Pharmaceutical Co Total Equity Chart

Shinpoong Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 214,893.42 380,095.45 360,324.40 330,758.29 270,782.15

Shinpoong Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 324,644.36 315,646.75 307,408.02 270,782.15 268,590.73

Shinpoong Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shinpoong Pharmaceutical Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=350083.64-79301.495
=270,782

Shinpoong Pharmaceutical Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=345827.77-77237.043
=268,591

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shinpoong Pharmaceutical Co Total Equity Related Terms

Thank you for viewing the detailed overview of Shinpoong Pharmaceutical Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shinpoong Pharmaceutical Co (XKRX:019170) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shinpoong Pharmaceutical Co Ltd (XKRX:019170) » Definitions » Total Equity
Comparable Companies
XKRX:001060 XKRX:003090 XKRX:003850 XKRX:000640 XKRX:086450 XKRX:243070 XKRX:170900 XKRX:249420 XKRX:003000 XKRX:003520 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
019175:Korea
Address
161, Yeoksam-ro, Gangnam-gu, Seoul, KOR, 06246
Website
https://shinpoong.co.kr
Shinpoong Pharmaceutical Co Ltd specializes in manufacturing remedy drugs and also active pharmaceutical ingredients and finished products. Its products include Newsicam, Caravenal, Roxagen, Clamoxin duo, Ceroxim, and Clocin. The firm's production facilities are located at Gyeonggi-do and Cheongwon-gun.

Shinpoong Pharmaceutical Co (XKRX:019170) Headlines

No Headlines